Seneca Biopharm Inc (SNCA)

1.66  -0.02 (-1.19%)

After market: 1.69 +0.03 (+1.81%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

Seneca Biopharm Inc

NASDAQ:SNCA (4/27/2021, 7:00:02 PM)

After market: 1.69 +0.03 (+1.81%)

1.66

-0.02 (-1.19%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap28.71M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

SNCA Daily chart

Company Profile

Seneca Biopharma Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel treatments for diseases of unmet medical need. Seneca Biopharma Inc., formerly known as Neuralstem Inc, is based in GERMANTOWN, Md.

Company Info

Seneca Biopharm Inc

20271 Goldenrod Lane

Germantown MD 20876

P: 301-366-4841

CEO: Kenneth Carter

SNCA News

News Image3 years ago - Seneca Biopharma, Inc.Seneca Biopharma Announces Successful Approval of Merger with Leading Biosciences, Inc.

- Proposed merger with Leading Biosciences, Inc. expected to close on or about Tuesday, April 27th, 2021

News Image3 years ago - Leading BioSciencesLeading BioSciences Announces Early Efficacy Signal in Reducing Post-Surgical Adhesions in Open Label Study
News Image3 years ago - Leading BioSciencesLeading BioSciences Provides Update to Seneca Biopharma, Inc. Stockholders on Merger Closing Process Following Virtual Special Meeting on April 23, 2021 and Upcoming Milestones Following Planned Close of Merger
News Image3 years ago - Leading BioSciencesLeading BioSciences Releases Video Message Encouraging Seneca Biopharma, Inc. Stockholders to Vote at the Virtual Special Meeting on April 23, 2021
News Image3 years ago - Seneca Biopharma, Inc.Seneca Biopharma, Inc. Announces (i) Voting Results from the Special Meeting of Stockholders and (ii) New Special Meeting Date of April 23, 2021

Five of six proposals related to merger transaction with Leading BioSciences were approved by Seneca stockholders at the Special Meeting of Stockholders held on April 9, 2021

News Image3 years ago - Leading BioSciencesLeading BioSciences Releases Video Message Highlighting Compelling Investment Thesis of Proposed Merger with Seneca Biopharma, Inc.

SNCA Twits

Here you can normally see the latest stock twits on SNCA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example